American Healthcare REIT, Inc. is a self-managed real estate investment trust (REIT). It acquires, owns and operates a diversified portfolio of clinical healthcare real estate properties, focusing primarily on outpatient medical buildings, senior housing, skilled nursing facilities (SNFs), and other healthcare-related facilities.
The Company operates through four segments: integrated senior health campuses, OM, triple-net leased properties and SHOP. Its integrated senior health campuses each provide a range of independent living, assisted living, memory care, skilled nursing services and certain ancillary businesses. Its OM buildings are typically leased to multiple tenants under separate leases.
Its triple-net leased properties segment includes senior housing, skilled nursing facilities and hospital investments. In addition, its triple-net leased properties segment includes its debt security investment. Its SHOP segment offers senior housing facilities..
| Price and Volume | |
|---|---|
| Volume | |
| Ten Day Average Volume | 2.1M |
| Three Month Average Volume | 33.0M |
| High Low | |
| Fifty-Two Week High | 21.45 USD |
| Fifty-Two Week Low | 12.63 USD |
| Fifty-Two Week High Date | 27 Aug 2024 |
| Fifty-Two Week Low Date | 07 Feb 2024 |
| Price and Volume | |
| Current Price | 20.93 USD |
| Beta | -100,000 |
| Relative Price Change | |
| Four Week Relative Price Change | 22.75% |
| Thirteen Week Relative Price Change | 33.39% |
| Twenty-Six Week Relative Price Change | 39.15% |
| Fifty-Two Week Relative Price Change | -99,999.99% |
| Year-to-Date Relative Price Change | -99,999.99% |
| Price Change | |
| One Day Price Change | 1.50% |
| Thirteen Week Price Change | 42.77% |
| Twenty-Six Week Price Change | 53.00% |
| Five Day Price Change | -0.38% |
| Fifty-Two Week Price Change | -99,999.99% |
| Year-to-Date Price Change | -99,999.99% |
| Month-to-Date Price Change | 31.30% |
| Per Share Data | |
|---|---|
| Book Value | |
| Book Value Per Share (Last Fiscal Year) | 19.18155 USD |
| Book Value Per Share (Most Recent Quarter) | 14.68602 USD |
| Tangible Book Value Per Share (Last Fiscal Year) | 12.90893 USD |
| Tangible Book Value Per Share (Most Recent Quarter) | 11.53821 USD |
| EBITD | |
| EBITD Per Share (Trailing Twelve Months) | 3.09651 USD |
| Revenue | |
| Revenue Per Share (Last Fiscal Year) | 28.26192 USD |
| Revenue Per Share (Trailing Twelve Months) | 21.25701 USD |
| Dividend | |
| Dividend Per Share (Last Fiscal Year) | -99999.99 USD |
| Dividend Per Share (Trailing Twelve Months) | 0.25 USD |
| Dividend Per Share (5 Year) | -99999.99 USD |
| Earnings Per Share | |
| Excluding Extraordinary Items (Last Fiscal Year) | -1.08209 USD |
| Excluding Extraordinary Items (Trailing Twelve Months) | -0.52789 USD |
| Normalized (Last Fiscal Year) | -1.10092 USD |
| Basic Excluding Extraordinary Items (Last Fiscal Year) | -1.08209 USD |
| Basic Excluding Extraordinary Items (Trailing Twelve Months) | -0.52787 USD |
| Including Extraordinary Items (Last Fiscal Year) | -1.08209 USD |
| Including Extraordinary Items (Trailing Twelve Months) | -0.52789 USD |
| Cash | |
| Cash Per Share (Last Fiscal Year) | 0.65601 USD |
| Cash Per Share (Most Recent Quarter) | 0.39566 USD |
| Cash Flow Per Share (Last Fiscal Year) | 1.60063 USD |
| Cash Flow Per Share (Trailing Twelve Months) | 1.56661 USD |
| Free Cash Flow Per Share (Trailing Twelve Months) | -1.52563 USD |
| Margins | |
|---|---|
| Cash Flow Revenue | |
| Cash Flow Revenue (5 Year) | -100,000 |
| Cash Flow Revenue (Trailing Twelve Months) | -7 |
| Pretax Margin | |
| Pretax Margin (Trailing Twelve Months) | -1.86% |
| Pretax Margin (Last Fiscal Year) | -4.08% |
| Pretax Margin (5 Year) | -99,999.99% |
| Gross Margin | |
| Gross Margin (Last Fiscal Year) | 19.52% |
| Gross Margin (Trailing Twelve Months) | 19.74% |
| Gross Margin (5 Year) | -99,999.99% |
| Operating Margin | |
| Operating Margin (Last Fiscal Year) | 2.47% |
| Operating Margin (Trailing Twelve Months) | 3.56% |
| Operating Margin (5 Year) | -99,999.99% |
| Net Profit Margin | |
| Net Profit Margin (Last Fiscal Year) | -4.12% |
| Net Profit Margin (Trailing Twelve Months) | -1.92% |
| Net Profit Margin (5 Year) | -99,999.99% |
| Growth | |
|---|---|
| Book Value | |
| Book Value Per Share (5 Year) | -99,999.99% |
| Tangible Book Value (5 Year) | -99,999.99% |
| Free Operating Cash Flow | |
| Free Operating Cash Flow (5 Year) | -99,999.99% |
| Revenue | |
| Revenue Change MRQ vs 1 Year Ago | 7.92% |
| Revenue Growth (3 Year) | -99,999.99% |
| Revenue Change (Trailing Twelve Months) | 8.47% |
| Revenue Per Share Growth | -99,999.99% |
| Revenue Growth (5 Year) | 14.47% |
| Capital Spending Debt | |
| Capital Spending (5 Year) | -99,999.99% |
| Total Debt (5 Year) | -99,999.99% |
| Dividends | |
| Dividend Growth (3 Year) | -99,999.99% |
| Earnings Per Share | |
| EPS Change MRQ vs 1 Year Ago | 108.21% |
| EPS Change (Trailing Twelve Months) | 64.76% |
| EPS Growth (3 Year) | -99,999.99% |
| EPS Growth (5 Year) | -99,999.99% |
| EBITDA | |
| EBITDA (5 Year) | -99,999.99% |
| EBITDA (5 Year Interim) | -99,999.99% |
| Net Profit Margin | |
| Net Profit Margin Growth (5 Year) | -99,999.99% |
| Valuation | |
|---|---|
| Total Price to Book | |
| Price to Tangible Book (Last Fiscal Year) | 3 |
| Price to Tangible Book (Most Recent Quarter) | 2 |
| Price to Free Cash Flow | |
| Price to Free Cash Per Share (Last Fiscal Year) | -100,000 |
| Price to Free Cash Per Share (Trailing Twelve Months) | -100,000 |
| Net Debt | |
| Net Debt (Most Recent Quarter) | 2.0B |
| Net Debt (Last Fiscal Year) | 2.5B |
| Price to Sales | |
| Price to Sales (Last Fiscal Year) | 1 |
| Price to Sales (Trailing Twelve Months) | 1 |
| Price to Earnings | |
| PE Excluding Extraordinary Items (Last Fiscal Year) | -100,000 |
| PE Normalized (Last Fiscal Year) | -100,000 |
| PE Basic Excluding Extraordinary Items (Trailing Twelve Months) | -100,000 |
| PE Excluding Extraordinary Items High (Trailing Twelve Months) | -100,000 |
| PE Excluding Extraordinary Items Low (Trailing Twelve Months) | -100,000 |
| PE Including Extraordinary Items (Trailing Twelve Months) | -100,000 |
| Dividends | |
| Dividend Yield (5 Year) | -99,999.99% |
| Dividend Yield | 4.78% |
| Current Dividend Yield | 1.19% |
| Price to Book | |
| Price to Book (Last Fiscal Year) | 1 |
| Price to Book (Most Recent Quarter) | 1 |
| Financial Strength | |
|---|---|
| Debt to Equity | |
| Long Term Debt to Equity (Last Fiscal Year) | 202 |
| Long Term Debt to Equity (Most Recent Quarter) | 106 |
| Payout Ratio | |
| Payout Ratio (Last Fiscal Year) | -99,999.99% |
| Payout Ratio (Trailing Twelve Months) | -99,999.99% |
| Quick Ratio | |
| Quick Ratio (Last Fiscal Year) | -100,000 |
| Quick Ratio (Most Recent Quarter) | -100,000 |
| Enterprise Value | |
| Current Enterprise Value to Free Cash Flow (Last Fiscal Year) | -100,000 |
| Current Enterprise Value to Free Cash Flow (Trailing Twelve Months) | -100,000 |
| Current Ratio | |
| Current Ratio (Last Fiscal Year) | -100,000 |
| Current Ratio (Most Recent Quarter) | -100,000 |
| Free Cash Flow | |
| Free Cash Flow (Last Fiscal Year) | -122,922,000 |
| Free Cash Flow (Trailing Twelve Months) | -140,020,000 |
| Net Interest Coverage | |
| Net Interest Coverage (Last Fiscal Year) | 0 |
| Net Interest Coverage (Trailing Twelve Months) | 1 |
| Total Debt to Equity | |
| Total Debt to Equity (Last Fiscal Year) | 202 |
| Total Debt to Equity (Most Recent Quarter) | 106 |
| Management Effectiveness | |
|---|---|
| Return on Assets | |
| Return on Assets (Last Fiscal Year) | -1.64% |
| Return on Assets (Trailing Twelve Months) | -0.81% |
| Return on Assets (5 Year) | -99,999.99% |
| Return on Equity | |
| Return on Equity (Last Fiscal Year) | -5.35% |
| Return on Equity (Trailing Twelve Months) | -2.16% |
| Return on Equity (5 Year) | -99,999.99% |
| Return on Investment | |
| Return on Investment (Last Fiscal Year) | -1.94% |
| Return on Investment (Trailing Twelve Months) | -0.94% |
| Return on Investment (5 Year) | -99,999.99% |